You are here
Press Releases
For press releases, media inquiries or to speak with a vascular surgeon, contact Kay Severinsen at (312) 334-2317 or by email. (No solicitors, please.)
September 25, 2018 • Press Release
JVS: Reliable new risk scoring tool can guide operative decisions for rAAA patients
PREOPERATIVE RISK SCORE TO PREDICT MORTALITY AFTER REPAIR OF RUPTURED ABDOMINAL AORTIC ANEURYSMS, Journal of Vascular Surgery, October 2018. CHICAGO, Illinois, Sept. 25, 2018 –An accurate new scoring tool using only pre-operative metrics can predict whether patients with a ruptured abdominal aortic aneurysm are likely to survive surgery. The condition is often a quick killer, and many patients don’t make it to the operating room, while others die after surgery.
September 4, 2018 • Press Release
What low-income patients need from providers
Low-income vascular patients need understanding from medical professionals
August 23, 2018 • Press Release
CAC shows good results in treating incompetent great saphenous veins
TWENTY-FOUR MONTH RESULTS FROM A RANDOMIZED TRIAL OF CYANOACRYLATE CLOSURE VERSUS RADIOFREQUENCY ABLATION FOR THE TREATMENT OF INCOMPETENT GREAT SAPHENOUS VEINS. Journal of Vascular Surgery Venous and Lymphatic Disorders. September 2018 CHICAGO, Illinois, September 2018 – New level I evidence reveals excellent mid-term results for a nonthermal, nontumescent (NTNT) technique to treat saphenous vein reflux for as long as two years after surgery.
August 20, 2018 • Press Release
LE Bypass and claudicant smokers
More evidence that lower extremity bypass may be a poor choice for claudicants who smoke ACTIVE SMOKING IN CLAUDICANTS UNDERGOING LOWER EXTREMITY BYPASS PREDICTS DECREASED GRAFT PATENCY AND WORSE OVERALL SURVIVAL. Journal of Vascular Surgery, September 2018. CHICAGO, Illinois, September 2018 – New research in the Journal of Vascular Surgery reports that even though smokers who undergo lower extremity bypass for claudication are healthier and around eight years younger than nonsmokers, their surgical outcomes are less successful.
July 23, 2018 • Press Release
AAA Patients Should Be Considered for Statin Therapy
STATIN THERAPY IS ASSOCIATED WITH HIGHER LONG-TERM BUT NOT PERIOPERATIVE SURVIVAL AFTER ABDOMINAL AORTIC ANEURYSM REPAIR. August, 2018. Journal of Vascular Surgery. CHICAGO, Illinois, August 2018 – New evidence reported in the August Journal of Vascular Surgery suggests that statin therapy has a significant survival benefit for those undergoing AAA repair. Journal of Vascular Surgery, August 2018.
